An injectable signal-amplifying device elicits a specific immune response against malignant glioblastoma.
Qiu Q, Chen S, He H, Chen J, Ding X, Wang D, Yang J, Guo P, Li Y, Kim J, Sheng J, Gao C, Yin B, Zheng S, Wang J.
Qiu Q, et al. Among authors: chen j, chen s.
Acta Pharm Sin B. 2023 Dec;13(12):5091-5106. doi: 10.1016/j.apsb.2023.06.010. Epub 2023 Jun 20.
Acta Pharm Sin B. 2023.
PMID: 38045037
Free PMC article.